Using Flow CAST® for the Development of a High Throughput, Objective Approach to Basophil Activation Image credit: Sarita U. Patil et al. (full citation below) DOWNLOAD eBOOK Webinar Recording Abstract We have developed and implemented a new data-driven, programmatic approach to the analysis of flow cytometry data from basophil activation testing. While conventional data analysis of flow
Continue Reading
Category: News
CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 98839 CALEX® Cap Extraction Video Rapid, Clean, Consistent and Safe Sample Preparation The CALEX®Cap extraction device is designed to fulfill the requirements and need in the market for convenient and safe stool extraction. BÜHLMANN has strived to provide the best stool extraction option for calprotectin testing and
Continue Reading
Quantum Blue® fCAL High Range Enhancements BUHLMANN is happy to introduce a revised and enhanced version of our Quantum Blue® fCAL high range test (LF-CHR25) to the market. The changes result in several beneficial features that not only further simplify the procedure but also improve performance characteristics. Enhancements and Benefits: Sample dilution NOW in extraction
Continue Reading
AMLI 2017 BUHLMANN Diagnostics Corp Booth: #13 August 13 - 16, 2017 Renaissance Stapleton Hotel | Denver, C0 LEARN MORE Click & Contact our AMLI 2017BUHLMANN Team Connect with our team ahead of time, learn more about the BÜHLMANN's Products and Solutions or schedule a meeting! Jennifer Stuart, Technical Sales Specialist JENNIFER STUART Technical Sales Specialist jls@buhlmannlabs.com
Continue Reading
Rosie Forster, Queen Elizabeth Hospital Birmingham, with the CALEX and Roche cobas c702 BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN
Continue Reading
BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 French Version Interview with Carmela Gugliotta, Laborgemeinschaft 1, Zurich Mrs. Gugliotta, several months ago you decided to implement the BÜHLMANN fCAL® turbo on your Roche cobas® c501 system. Can you tell me why? Our customers asked
Continue Reading
AACC 2017 BUHLMANN Diagnostics Corp Booth: #1620 July 30 – August 3 2017, 2017 San Diego Convention Center | San Diego, CA LEARN MORE Click & Contact AACC 2017 BUHLMANN Team Connect with our team ahead of time, learn more about the BÜHLMANN's Products and Solutions or schedule a meeting! Collin Shaw, VP of Business Development
Continue Reading
BUHLMANN Diagnostics Corp is proud to release the third edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this edition,
Continue Reading
Digestive Diseases Week (DDW) 2017 BUHLMANN Diagnostics Corp Booth: #1925 May 06 - 09, 2017 | McCormick Place | Chicago, IL Learn More Click & Contact DDW 2017 BUHLMANN Team Connect with our team ahead of time, learn more about our Calprotectin Assays or schedule a meeting! Collin Shaw, VP of Business Development Jennifer Stuart, Technical
Continue Reading
BÜHLMANN GanglioCombi® MAG ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100476 DOWNLOAD WHITE PAPER BÜHLMANN GanglioCombi® MAG ELISA Comprehensive assay for anti-MAG and most prevalent anti-Ganglioside antibodies: (GM1, GM2, GD1a, GD1b, and GQ1b). The Neuroimmunology product line by BÜHLMANN is a list of robust assays for simple, esoteric
Continue Reading
